We here report the existence of a new cluster of adhesion-GPCRs in human immune cells. Analysis of a comprehensive immune cell transcriptome dataset indicated that expression of the closely related receptors, GPR56, GPR97, and GPR114, is associated with single lymphocyte and granulocyte subsets. Applying flow cytometric analysis with newly generated mAb, we show that expression of GPR56 is restricted to cytotoxic NK and T lymphocytes, including CD8 ϩ , CD4 ϩ , and ␥␦ T cells. Primary infection with human CMV, which generates a vast population of CD8 ϩ T cells with an effector phenotype, induced a strong increase in GPR56 expression in virus-specific CD8 ϩ T cells that remained detectable during latency. In NK-92 cells, ectopic expression of GPR56 inhibited spontaneous and SDF-1-stimulated cell migration. Our data suggest that GPR56 expression is a common trait of human cytotoxic lymphocytes and might affect the migratory properties of these cells. J. Leukoc. Biol. 90: 000 -000; 2011.
Introduction
The adhesion class of GPCRs comprises 33 members in humans with a broad cellular distribution in the developing embryo, the reproductive tracts, and the nervous and the immune system [1, 2] . Adhesion-GPCRs differ from classical GPCRs by their unusual molecular structure. Intramolecular processing at a GPCR-proteolytic site proximal to the first transmembrane helix gives rise to a membrane-spanning and an extracellular subunit, which reassociates noncovalently, resulting in expression of a heterodimeric receptor at the cell surface. The extracellular subunits of adhesion-GPCRs are exceptionally long and contain a variety of structural domains that can facilitate cell-cell and cell-matrix interactions. Ligand profiles and in vitro studies have indicated a role of adhesionGPCRs in cell adhesion and migration. More recent evidence, coming forth from genetic models, has confined this concept by suggesting that the primary function of adhesion-GPCRs may relate to the proper positioning of cells in a variety of organs [3] . However, despite much research interest, neither the mechanisms of activation nor the downstream signaling pathways of these nonclassical GPCRs are understood yet. Another shortcoming is the poor, basic characterization of many adhesion-GPCRs; approximately one-half of them has not been studied at the protein level.
Immune cells express a group of adhesion-GPCRs with Nterminal EGF-like domains, called EGF-TM7 receptors [4] . Whereas the EGF-TM7 family member CD97 is widely present on almost all leukocytes, expression of its relatives EMR1-4 (EMR1 is the human homologue of mouse F4/80) is restricted to myeloid cells, including monocytes, macrophages, DCs, and granulocytes. Whether leukocytes also express other adhesionGPCRs has not been studied yet systematically. In a recent report, Della Chiesa and coworkers [5] described GPR56 as a novel marker for CD56 dull cytotoxic NK cells. We here report that a cluster of adhesion-GPCRs, comprising GPR56, GPR97, and GPR114, is expressed in immune cells. With the use of newly generated mAb, we show that GPR56 expression identifies cytotoxic NK and T cells. We demonstrate that virus-specific CD8 ϩ T cells stably express GPR56 during human CMV infection. Finally, we provide evidence that GPR56 might regulate lymphocyte migration.
GPR56 overexpression
CHO-K1 cells were transfected with pcDNA3.1-based expression constructs encoding GPR56 or EMR2 as described previously [9] . NK-92 cells were infected with a pFB-Neo retroviral expression construct (Stratagene, La Jolla, CA, USA) encoding GPR56, using protocols described previously [10] . Stable NK-92 cells were selected in culture medium containing IL-2 (100 U/ml) and G418 (0.5 mg/ml) for 14 days.
Western blot analysis
Total cell lysates of tranfected CHO-K1 cells were separated in 10% SDS/ PAGE gel and subjected to standard Western blot analysis. CG1-5 or 2A1 (anti-EMR2) mAb (5 g/ml) were used as the primary antibody, followed by HRP-conjugated anti-mouse IgG (1:1000) as the secondary antibody.
Flow cytometry
Mononuclear cells were isolated from heparinized peripheral blood from healthy individuals using standard density gradient centrifugation techniques and Lymphoprep (Axis-Shield, Oslo, Norway). NK-92 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). For flow cytometry analysis, on average, 3 ϫ 10 5 cells were incubated with fluorescent label-conjugated mAb as described [11] . Antibodies with the following specificities were used: CD3 (clone SK7, labeled with APC, PerCPCy5.5, or APC-H7), CD4 (clone SK3, labeled with PerCP-Cy5.5 or PE-Cy7), CD8 (clone SK1, labeled with PerCp-Cy5.5), CD19 (clone SJ25C1, labeled with PerCP-Cy5.5), CD20 (clone L27, labeled with APC), CD28 (clone CD28.2, labeled with APC), CD56 (clone B159, labeled with APC), CD94 (clone HP-3D9, labeled with APC), and TCR␥␦ (clone B1, labeled with FITC; all BD Biosciences, San Diego, CA, USA); CD16 (clone 3G8, labeled with APC; Caltag Laboratories, Burlingame, CA, USA); CD27 (clone CLB-CD27/1-9F4, labeled with FITC) and granzyme B (clone GB11, labeled with PE; both Sanquin, Amsterdam, The Netherlands); CD45RA (clone 2H4-B, labeled with PE), TCRV␣24 (clone C15, labeled with FITC), and TCRV␤11 (clone C21, labeled with PE; Beckman-Coulter, Fullerton, CA, USA); and CD57 (clone NC1, labeled with FITC; Immunotools, Friesoythe, Germany). PE-and APC-conjugated goat anti-mouse-Ig (Beckman-Coulter and BD Biosciences, respectively) was used as a second-step reagent. Staining with APC-conjugated HLA-A0201 tetramer, loaded with CMV immediate early protein 1-derived peptide VLEETSVML, was performed as described [7] . Flow cytometry analysis was performed using FACSCalibur and FACSCanto machines (BD Biosciences) and the FlowJo software package (Tree Star, Ashland, OR, USA).
Transwell migration
Retrovirally transduced NK-92 cells (2ϫ10 5 ), starved in serum-free RPMI-1640 medium containing 0.3% BSA and 100 U/ml IL-2 at 37°C for 6 h, were loaded in a volume of 100 l on transwell filters with a pore size of 5 m (Corning, Corning, NY, USA). SDF-1 (CXCL12) was added as chemoattractant to the lower compartment at various concentrations. After 2.5 h incubation at 37°C, cells in the lower compartment were harvested and quantified by flow cytometry at a fixed, high speed for 105 s. A two-tailed unpaired t test was used to compare the levels of migration.
RESULTS AND DISCUSSION

Transcription of GPR56, GPR97, and GPR114 in leukocytes
By using Affymetrix microarrays, we recently developed transcript profiles for all major human leukocyte populations, including neutrophils, eosinophils, basophils, mast cells, macrophages, DCs, NK cells, and B and T cell subsets [6] . This dataset, which allows the identification of genes expressed in immune cells, was used to analyze the expression pattern of adhesion-GPCRs. Next to the members of the EGF-TM7 family, CD97, EMR1, EMR2, and EMR3, we identified three novel receptors with distinct gene expression profiles in human leukocytes (Fig. 1A) . These receptors, called GPR56, GPR97, and GPR114, are structurally similar molecules with an extracellular region of 250 -400 aa (Fig. 1B) . The genes encoding GPR56, GPR97, and GPR114 cluster on the long arm of chromosome 16, suggesting a common evolutionary origin (Fig. 1C) . High levels of the GPR56 transcript were detected in NK cells, effector/ memory T cells, and ␥␦ T cells. Transcripts of GPR97 and GPR114 were primarily found in granulocytes, and GPR114 was present in eosinophils and GPR97 in neutrophils and eosinophils. Other adhesion-GPCRs, present on the Affymetrix arrays [BAI1-3, CELSR1-3, ELTD1 (ETL), LPHN1-3, GPR64 (HE6), GPR98 (VLGR1), GPR110, GPR115, GPR116, GPR123, GPR124, GPR125, GPR126, GPR133, and GPR144], were not expressed in leukocytes (Supplemental Fig. 1 ).
Generation of GPR56-specific mAb
To start with the characterization of the newly identified adhesion-GPCRs on immune cells, we generated mAb against human GPR56, using soluble GPR56-mFc protein as the antigen (Supplemental Fig. 2A) . A total of five hybridoma clones, CG1-5, producing mouse anti-human GPR56 mAb, was successfully established. The specificity and utility of these mAb were evaluated by Western blot analysis and flow cytometry.
Western blot analysis showed that all mAb recognize the purified GPR56-mFc protein (Supplemental Fig. 2B ). Moreover, CG2, CG3, and CG4 detected a specific 60-to 75-kDa fragment in the cell lysate of GPR56-but not mock-and EMR2-transfected CHO-K1 cells. By flow cytometry of transfected CHO-K1 cells, a clear surface staining of GPR56 was obtained with CG2 and CG4 (Supplemental Fig. 2C ).
Expression of GPR56 by cytotoxic lymphocytes
With the use of mAb CG4, we characterized the expression of GPR56 on circulating human leukocytes. In line with Della Chiesa et al. [5] , we found abundant GPR56 expression on cytotoxic CD56
dull NK cells but not on the developmentally and functionally less-mature CD56 bright cells ( Fig. 2A) . Subdivision of the CD56 dull population, based on CD94 surface density [12] , revealed a small but consistent increase in GPR56 expression during the transition from intermediary CD94 high to fully mature CD94 low cytotoxic NK cells. We next studied different T cell lineages. NKT cells, a separate population of T cells that coexpresses invariant TCR and NK-lineage molecules and executes effector functions by the production of large amounts of IFN-␥ [13] , did not express GPR56 (data not shown). CD8
ϩ T cells can be subdivided, based on the expression of CD27 and CD45RA, into naive, memory-type, and effector-type cells [14] , Although CD27 -CD45RA ϩ effector-type cells strongly expressed GPR56, staining was very weak on memory cells and absent on naive cells (Fig. 2B) . Similarly, naive and memory CD4 ϩ T cells did not express GPR56 (Fig. 2C ). Cytotoxic CD4 ϩ T cells that lack expression of CD27 and CD28 are rare in normal subjects but emerge as a consequence of chronic viral infection [15] . In a CMV-positive donor with large numbers of cytotoxic CD4 ϩ T cells, we found expression levels of GPR56 on CD4 ϩ CD27 -cells comparable with that on cytotoxic NK cells and CD8 ϩ T cells (Fig.   2C , right panel). Expression of GPR56 correlated even better with lack of CD28, which strictly defines cytotoxic CD4 ϩ T cells (data not shown). Finally, we analyzed ␥␦ T cells, a small population of functionally variable T lymphocytes [16] . Again, expression of GPR56 was restricted to CD27 -CD45RA ϩ effector-type cells, which all were GPR56 ϩ (Fig. 2D ). In conclusion,
we found abundant and highly specific expression of GPR56 in all cytotoxic subsets of NK and T lymphocytes. Expression of GPR56 completely overlapped with the presence of the cytolytic enzymes perforin, granzyme A, and granzyme B in these cells (Fig. 2E) . Noncytotoxic NK and T cells, B cells, and myeloid cells, including granulocytes, monocytes, and DCs, did not express GPR56 (data not shown). Persistent infection with CMV results in a strong increase in virus-specific, effector-type CD8 ϩ T cells with key features such as cytolytic potential, IFN-␥ production, and migratory capacity [7] . With the use of expression profiling of CMV-specific CD8 ϩ T cells of renal transplant recipients experiencing primary CMV infection after receiving a CMV-seropositive donor organ, we observed a strong up-regulation of GPR56 gene expression during the peak of the response, followed by a further increase until 1 year after viral infection (Fig. 3A) . Kinetics of GPR56 expression closely correlated with the expression of B3GAT1, the glucuronyltransferase that generates CD57, and KLRG1, both markers of replicative senescence [17] [18] [19] . Analysis of protein expression revealed that CD8 ϩ T cells, specific for the CMV immediate early protein 1, expressed similar levels of surface GPR56 during all phases of the response, even at 5 years after viral infection (Fig. 3B) 
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Ectopic expression of GPR56 inhibits lymphocyte migration
Functional maturation affects the migratory properties of lymphocytes [7] . Iguchi and coworkers [20] previously demonstrated that ectopic expression of GPR56 in neural progenitor cells negatively regulates migrating activity. With the use of retroviral transduction, we expressed GPR56 in NK-92, a cytotoxic NK cell line that lacks GPR56 expression, independent of its reliance on IL-2 (Fig. 4A, and data not shown) . In line with the effect of GPR56 overexpression in neural progenitor cells, ectopic expression of GPR56 reduced spontaneous transwell migration of NK-92 cells by ϳ70% (Fig. 4B) . Upon stimulation with SDF-1 (CXCL12), transmigration of GPR56-expressing cells was reduced by 70 -80% as compared with control NK-92 cells. Hence, expression of GPR56 might regulate the migratory capacity of cytotoxic lymphocytes.
Concluding remarks
GPR56 was discovered independently in human heart tissue and melanoma cells by two studies in 1999 [21, 22] . Later work demonstrated a role of GPR56 in brain development. Mutations in various parts of the receptor were found to cause a human brain cortical malformation, called bilateral frontoparietal polymicrogyria [23, 24] , which is mirrored in mice lacking a functional Gpr56 gene [25] . A critical role for GPR56 in the adhesion of developing neurons to basal lamina molecules and consequently, the proper positioning of these cells were demonstrated [26] . Other studies found GPR56 in hematopoietic and neuronal stem cells [27, 28] and in a variety of tumors, including melanomas, gliomas, and different carcinomas [29 -31] . Binding of mouse GPR56 to tissue transglutaminase 2 inhibited melanoma growth and spreading [30] . Biochemical studies revealed association of GPR56 with the tetraspanin CD81 in the cell membrane and engagement of different G ␣ proteins [32] ; however, as for other adhesion-GPCRs, a link between receptor ligation and downstream signaling has not been established.
We here describe the expression of GPR56 in immune cells, thereby confirming a recent report that described GPR56 as novel marker for CD56 dull lymphocytes. With the use of protein purification and sequencing, Della Chiesa and colleagues [5] identified the antigen recognized by two mAb with specificity for circulating and sessile NK cells as GPR56. Our study aimed to find novel adhesion-GPCRs on immune cells. We , GZMA (granzyme A), GZMB (granzyme B), B3GAT1 (the glucuronyltransferase that generates the CD57 epitope), and KLRG1 in naïve cells in CMV-specific cells from renal transplant recipients at peak of and 1 year after infection was analyzed by hybridizing Agilent microarrays with cRNA from sorted peripheral blood leukocytes of three individual donors [7] . Expression is depicted as fold-change compared with naïve CD8 GPR56-and neo-transduced NK-92 were allowed to transmigrate for 2.5 h through 5-m transwell filters in the absence or presence of 10 -100 ng/ml SDF-1 in the lower compartment. Cells that migrated through the filter were quantified by flow cytometry. Indicated is the relative mean Ϯ sd (untreated, neo-transduced cellsϭ100%) of three independent experiments. *P Ͻ 0.05; **P Ͻ 0.005.
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